Cancer Care through Early Detection & Intervention: NFCR

Transformative Therapies

Transformative Therapies

What is Transformative Therapies?

Transformative cancer therapies are groundbreaking treatment modalities that leverage novel biological mechanisms to improve therapeutic outcomes over standard-of-care regimens. These innovative approaches often exploit recent scientific discoveries to target cancer through distinct mechanisms.

Examples of transformative therapies include gene and viral therapies modifying genetic material, immunotherapies harnessing the immune system, targeted therapies against specific molecular drivers, and novel therapeutic platforms like antibody-drug conjugates. These cutting-edge treatments aim to overcome limitations of conventional cytotoxic chemotherapies.

NFCR-Supported Researchers Working on Transformative Therapies

Yung-Chi Cheng, Ph.D.

Yung-Chi Cheng, Ph.D.
Yale University

Katherine Uyhazi, M.D., Ph.D.
University of Pennsylvania Perelman School of Medicine

Tomas Aleman, M.D.
University of Pennsylvania Perelman School of Medicine

Susan Band Horwitz, Ph.D.
Albert Einstein College of Medicine

Related Content

Innovative Therapies

Promising innovations to treat and prevent cancer